EX-23.1 3 curr_ex231.htm CONSENT curr_ex231.htm

EXHIBIT 23.1

 

Consent of Independent Registered Public Accounting Firm

 

The Board of Directors and Stockholders

CURE Pharmaceutical Holding Corp

 

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-227791) of CURE Pharmaceutical Holding Corp and subsidiaries of our report, which includes an explanatory paragraph regarding the substantial doubt about the Company's ability to continue as a going concern, dated April 1, 2019, relating to the consolidated financial statements which appears in this Form 10-K.

 

 

/s/ RBSM LLP

 

April 1, 2019

Henderson, NV